Max Osipov Email

Associate Director and Principal Scientist . Denali Therapeutics

South San Francisco, CA

Location

o*****@dnli.com

Primary Email

Current Roles

Employees:
517
Revenue:
$353M
About
Denali Therapeutics Inc. (Denali) is a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, ALS and others. Denali was founded by scientists, industry experts and investors who share the vision that recent scientific insights into the genetic causes and biological processes underlying neurodegenerative disease, together with new translational medicine tools, offer an unprecedented opportunity to discover and develop effective medicines. Denali is rigorously pursuing a science-driven approach to translational medicine and clinical development. Founding investors include Fidelity Biosciences, ARCH Venture Partners, Flagship Ventures and the Alaska Permanent Fund (represented by Crestline Investors).
Denali Therapeutics Address
161 Oyster Point Blvd
South San Francisco, CA
United States
Denali Therapeutics Email

Past Companies

Denali TherapeuticsAssociate Director and Principal Scientist
Denali TherapeuticsPrincipal Scientist and Senior Lab Leader
Denali TherapeuticsSenior Scientist and Senior Lab Leader

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.